Date Title Alternative
2024-03-01 Coverage paused Download | Show Close
Research | 1 Mar 2024 | Irisity

Coverage paused

 

Q4 fell short of guidance

Revenues for the quarter were SEK27.6m, implying growth of 121% Y/Y. This was short of guidance for SEK37–42m. The shortfall was the result of four factors: 1) a higher share of monthly recurring revenue contracts, 2) negative currency effects of around SEK 0.5m, 3) regulatory delays to Swedish municipality products, 4) delays in Europe and the Middle East owing to ongoing conflicts in the regions. One aspect of the report that stuck out was the company’s record-high gross margin of 94.1%. EBITDA for the quarter came in at SEK-12.7m. This was weighed down by a negative non-cash flow impacting item of SEK 8.7m stemming from currency revaluation of a loan to Agent Vi.

Acquisition broadens tech and offering

Following the close of the quarter, the company acquired Ultinous, based in Sweden and Hungary. The acquisition will complement Irisity’s technology in edge computing, broadening its offering within the Nvidia ecosystem. It also expands its offering to include several functions in practical security, having previously focused on surveillance security. Irisity sees cost and revenue synergies through this acquisition, as Ultinous can utilise Irisity’s global sales channels. The acquisition is paid for with a non-cash issue of nine million shares at SEK5 per share. In conjunction with the acquisition, Irisity is carrying out a directed share issue on the same terms as the non-cash issue to bolster its liquidity and financial position. The two issues lead to a dilution of 26.8%.

 

Coverage paused

As Penser by Carnegie, Carnegie Investment Bank AB is acting as an advisor in the transaction, we pause our coverage of the share. Our estimates have not been updated and should no longer be relied upon.

 

2024-01-31 Volume update on UK project Download | Show Close
2023-11-15 Guidance reiterated, but with reduced visibility Show Close
2023-10-04 A new deal Show Close
2023-08-15 Full-year guidance suggests growth has returned Show Close
2023-05-15 Working through 2022 order book Show Close
2023-02-28 Order book shows growth returning Show Close
2022-11-15 Most challenges lie ahead Show Close
2022-08-17 Organic growth accelerates Show Close
2022-05-25 Capital Market Day sets the pace going forward Show Close
2022-02-21 MRR growth and gross margin reach record highs Show Close
2021-08-09 Accelerating growth Show Close
2021-05-10 In line with our expectations and confirms commercialization plan Show Close